Providing effective treatment for those with cannabis use disorders is likely to become a matter of growing importance in European drug policy. This is according to the EU drugs agency (EMCDDA) today as it launches a new in-depth study: Treatment of cannabis-related disorders in Europe.
Źródło: http://www.emcdda.europa.eu